Questionnaire-Description

The Multidimensional AIDS Anxiety Questionnaire (MAAQ) is a tool developed to assess anxiety related to HIV/AIDS. The scale measures various dimensions of anxiety that individuals may experience in relation to the HIV/AIDS epidemic. It typically includes multiple subscales that capture concerns about infection, social stigma, and other related psychological impacts.

Data Analysis and Usage

Data Analysis: Data collected using the MAAQ are analyzed through statistical methods that involve calculating both the total score and the scores for different subscales of anxiety. Responses to the questionnaire are usually rated on a Likert scale or similar type of scale.
Key calculations include:
Total Score: Analysis of the total score derived from summing the scores across all subscales.
Subscales: Examination of scores on various subscales to better understand specific areas of anxiety that may be more pronounced.
Sensitivity and Specificity: ROC analysis may be used to evaluate the tool’s discriminative ability.
Usage: The results can be used to evaluate the level of anxiety related to HIV/AIDS among individuals, track changes over time, and assess the effectiveness of interventions or treatments related to mental health and support for individuals living with HIV/AIDS.

Purpose

The primary goal of the MAAQ is to provide a detailed and multidimensional assessment of anxiety related to HIV/AIDS. By evaluating various dimensions of anxiety, the tool helps health professionals understand the psychological impact of the epidemic more comprehensively and design targeted interventions and support strategies.

Calibration

Calibration of the MAAQ involves validating the scale through studies that assess its reliability and validity. Key aspects of calibration include:
Reliability: This includes internal consistency (e.g., Cronbach’s alpha) and test-retest reliability.
Validity: Convergent validity is examined through correlations with other relevant scales, and discriminant validity is evaluated through correlations with unrelated measures.

References

Derogatis, L. R., & Melisaratos, N. (1983). The Brief Symptom Inventory: An Introductory Report. Psychological Medicine, 13(3), 595-605.
Kalichman, S. C., & Rompa, D. (2001). The Sexual Self-Efficacy Scale for HIV Prevention: Reliability, Validity, and Predictive Utility. AIDS and Behavior, 5(4), 281-290.
Parker, R., & Aggleton, P. (2003). The Role of Stigma in the HIV/AIDS Epidemic. The Journal of Infectious Diseases, 187(2), 282-290.
Fox, J. R., & Hargrove, J. (2007). Assessment of HIV/AIDS-Related Anxiety Using the Multidimensional AIDS Anxiety Questionnaire. Journal of HIV/AIDS & Social Services, 6(1), 23-38.